Stay updated on ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial

Sign up to get notified when there's something new on the ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The revision tag on the page was updated from v3.6.3 to v3.6.4. This indicates a maintenance update to the page's template and metadata rather than to its visible content.
    Difference
    0.1%
    Check dated 2026-07-25T13:00:50.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.2 to v3.6.3, signaling a small release update to the page.
    Difference
    0.1%
    Check dated 2026-07-03T23:53:36.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, signaling a backend/template update applied to the study page rather than a change to the clinical trial data.
    Difference
    0.1%
    Check dated 2026-06-26T22:26:49.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Added new help/navigation sections: How to Read a Study Record, Common Questions, and How to Join a Study, and standardized the Intervention/Treatment heading. The previous revision note Revision: v3.5.5 was removed and replaced with Revision: v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-12T12:20:35.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.4 to v3.5.5, indicating a newer page build. This reflects a newer version of the page release.
    Difference
    0.1%
    Check dated 2026-06-05T08:26:03.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    Updated revision tag from v3.5.3 to v3.5.4, indicating a newer version of the page metadata.
    Difference
    0.1%
    Check dated 2026-05-15T04:13:59.000Z thumbnail image

Stay in the know with updates to ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial page.